[PDF] Top 20 Análisis a la gestión de recaudo del impuesto predial en el municipio de Cotorra

... selected group of patients with Graves’ hyperthyroidism who had no GO at the time of recruitment and were treated with anti-thyroid drugs, from a single ... See full document

... of disease classification at a clinical ...the European Group on Graves’ Orbitopathy (EUGOGO) and the recent formation of the International Thyroid Eye Disease Study ... See full document

... the disease, and include the restoration of euthyroidism in all patients; selenium supple- mentation for those affected by mild TAO; immunosup- pressive therapy and radiotherapy for active TAO; and decompression ... See full document

... whereas Graves’ disease develops from 3 to 12 months ...with Graves’ disease commonly relapse during the postpartum period, even if they were in remission before pregnancy [21, 24, ...thyroid ... See full document

... Adverse drug reactions: MMI and PTU have similar side effects although they occur more often and are more severe with PTU. Side effects from ATD can be divided as minor and major depending on the severity. Minor side ... See full document

... early in pregnancy to evaluate the risk for fetal hyperthyroidism. If the level is high, careful monitoring of the fetus is mandatory for the early detection of signs of thyroid overstimulation (pulse rate > 170 bpm, ... See full document

... In recent years, several articles have been published on the development of Graves’ disease shortly after radioactive iodine therapy for AFTNs. The inci- dence of this event is significantly higher, ... See full document

... Some populations show an association between -318 SNP of CTLA-4 gene and Graves’ disease (Park et al., 2000), while others do not (Kouki et al., 2002; Vaidya et al., 2003; Zhang et al.,2006). ... See full document

... Employing a dual thyroxine tracer system, we were able to demonstrate that during the early phases of equilibration of a tracer dose of thyroxine, alterations in the rate of deiodination were observed to be present in ... See full document

... There are other molecules mediating the immunomodu- latory events of MSCs such as IL-10, human leukocyte antigen G (HLA-G) [52–54], and leukemia inhibitory factor (LIF) [55], the latter of which plays a critical role in ... See full document

... Thyroid – stimulating immunoglobulins (TSI) have now replaced LATS as the suspect humoral factor. These IgG immunoglobulins, undetected by the LATS assay, have been found in the sera of over 90% of Graves’ ... See full document

... Thymic enlargement (TE) in Graves’ disease (GD) is often diagnosed incidentally when chest imaging is done for unrelated reasons. This is becoming more common as the frequency of chest imaging increases. ... See full document

... In this study, texts were reviewed, and internet searches and library studies were conducted during the time period 2007 to 2016. Databases such as Science Direct, Google Scholar, Ovid, and MEDLINE, which index the vast ... See full document

... cardiac disease was excluded and in whom the presence of thyroid nodules was taken into account in the analysis; (ii) achievement of the targeted absorbed dose of 60 Gy with an acceptable coefficient of variation; ... See full document

... CAS was not developed until 1999, which was also the year that EUGOGO was founded. Furthermore, some of the subjects in our study were diagnosed prior to 1999. Thus, it was not possible to use CAS in all the ... See full document

... Although the average total dose of radioiodine in millicuries exceeds that given the University of California group and was administered as a single dose, the estimated number of microcu[r] ... See full document

... with Graves' disease and treated with thionamide drugs for 3-7 mo before subtotal thyroidectomy, from 12 patients with Graves' disease, similarly treated, and given 50 mug of triiodothyronine ... See full document

... A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease CASE REPORT A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease Z Hussein, MRCP*, B Tress**,[.] ... See full document

... processes includes matrix degradation and an imbalance between MMPs and their specific inhibitors, TIMPs. TIMPs play important roles in maintaining the delicate balance between ECM production and disposal. Changes in  ... See full document

... The frequencies of responses on the Thai GO-QOL are presented in Table 2. The percentage of com- pleted responses for each item was 100%. Seriously limited activities were described by 48.6% of patients for reading, by ... See full document